Clinical translation of perinatal cells in an academic facility
Originally recorded May 21, 2019 | 12:00 PM CDT
Perinatal cells offer a promising opportunity for a wide range of regenerative medicine applications because of their unique immune modulatory properties, rather than their differentiation ability. In this webcast presented by Dr. Julie Allickson, Director of the Regenerative Medicine Clinical Center at Wake Forest Institute for Regenerative Medicine, where she provides information on clinically translating perinatal cells in an academic facility.
Watch to learn more about clinical translation of perinatal cells, including:
- Steps in clinical translation of cell therapy products
- An accelerated model of translation in an academic environment
- Assessing perinatal tissues and cells in pre-clinical studies
Complete the form to view the webcast.
About Share the ScienceShare the Science is a free webinar series designed to bring you powerful presentations by the top experts in cellular therapy. Generously supported by WellSky and Save the Cord Foundation, Share the Science webinars connect you to the world's most innovative and influential scientists, clinical researchers, and experts as they highlight the latest breakthroughs and most promising developments in cellular therapy.
Learn more about Save the Cord Foundation.